-
Progyny Inc. (PGNY $23.46)
- $23.46 P/E (TTM): 40.32X Cap: $1.96B
- View PGNY Profile
- View Questions on PGNY
Detailed Quote
Questions on this company?
Become a Member
Company Profile
{tplLang.businessdescription | toLang tLang}
{ profileData.description }
{tplLang.details | toLang tLang}
{tplLang.ceo | toLang tLang}
{profileData.profile.details.ceo}
{tplLang.employees | toLang tLang}
{profileData.profile.details.employees | numeraljs '0,0'}
{tplLang.issuetype | toLang tLang}
{profileData.profile.details.issuetype | asIssueType}
{tplLang.industryclassifications | toLang tLang}
{tplLang.sector | toLang tLang}
{profileData.profile.classification.sector}
{tplLang.industry | toLang tLang}
{profileData.profile.classification.industry}
{tplLang.toolname| toLang tLang}
There is no {tplLang.toolname| toLang tLang} currently available for
{data.symbolstring}.
Interactive Chart
Key Ratios
Earnings
Analyst Recommendations
5i Recent Questions
-
Progyny Inc. (PGNY $23.46)
- $23.46 P/E (TTM): 40.32X Cap: $1.96B
- View PGNY Profile
- View Questions on PGNY
Q: Do you see the recent dip in PGNY as an opportunity or did the recent results indicate something worrying? Do you agree with the assessment that there could be long-term, above-average growth possibilities and PGNY is emerging as a leader rather than just simply another OK investment?
-
Veeva Systems Inc. Class A (VEEV $286.01)
- $286.01 P/E (TTM): 60.55X Cap: $46.60B
- View VEEV Profile
- View Questions on VEEV
-
Progyny Inc. (PGNY $23.46)
- $23.46 P/E (TTM): 40.32X Cap: $1.96B
- View PGNY Profile
- View Questions on PGNY
Q: I'm reviewing my portfolio to evaluate if there are any names i've held for a few years which haven't done much or i'm down on, and may be candidates to be sold and replaced with growthier names that have become more attractive. The 2 names that meet the criteria are VEEV and PGNY. With a focus on growth do you think either of these names should be sold and replaced or are they holds? Thx
-
STERIS plc (Ireland) (STE $225.47)
- $225.47 P/E (TTM): 36.08X Cap: $22.18B
- View STE Profile
- View Questions on STE
-
Progyny Inc. (PGNY $23.46)
- $23.46 P/E (TTM): 40.32X Cap: $1.96B
- View PGNY Profile
- View Questions on PGNY
-
Simulations Plus Inc. (SLP $13.27)
- $13.27 Cap: $262M
- View SLP Profile
- View Questions on SLP
-
Lantheus Holdings Inc. (LNTH $73.31)
- $73.31 P/E (TTM): 20.61X Cap: $5B
- View LNTH Profile
- View Questions on LNTH
Q: Hello,
I've had these three healthcare companies on my watchlist for some time. Can I get your up-to-date assessment of each re: growth prospects and balance sheet stability? Would you consider any of them to be a buy and if so, in what order and is the current valuation reasonable?
Thank you, Doris
I've had these three healthcare companies on my watchlist for some time. Can I get your up-to-date assessment of each re: growth prospects and balance sheet stability? Would you consider any of them to be a buy and if so, in what order and is the current valuation reasonable?
Thank you, Doris
Insiders
Share Information
SEC Filings
News and Media